Effects of Extracorporeal CO Removal on Gas Exchange and Ventilator Settings: a Systematic Review and Meta-analysis

Overview

Journal Crit Care

Specialty Critical Care

Date 2024 May 1

PMID 38693569

Authors

Alexandra-Maria Stommel

Harald Herkner

Calvin Lukas Kienbacher

Brigitte Wildner

Alexander Hermann

Thomas Staudinger

Affiliations

Soon will be listed here.

Abstract

Purpose: A systematic review and meta-analysis to evaluate the impact of extracorporeal carbon dioxide removal (ECCOR) on gas exchange and respiratory settings in critically ill adults with respiratory failure.

Methods: We conducted a comprehensive database search, including observational studies and randomized controlled trials (RCTs) from January 2000 to March 2022, targeting adult ICU patients undergoing ECCOR. Primary outcomes were changes in gas exchange and ventilator settings 24 h after ECCOR initiation, estimated as mean of differences, or proportions for adverse events (AEs); with subgroup analyses for disease indication and technology. Across RCTs, we assessed mortality, length of stay, ventilation days, and AEs as mean differences or odds ratios.

Results: A total of 49 studies encompassing 1672 patients were included. ECCOR was associated with a significant decrease in PaCO, plateau pressure, and tidal volume and an increase in pH across all patient groups, at an overall 19% adverse event rate. In ARDS and lung transplant patients, the PaO/FiO ratio increased significantly while ventilator settings were variable. "Higher extraction" systems reduced PaCO and respiratory rate more efficiently. The three available RCTs did not demonstrate an effect on mortality, but a significantly longer ICU and hospital stay associated with ECCOR.

Conclusions: ECCOR effectively reduces PaCO and acidosis allowing for less invasive ventilation. "Higher extraction" systems may be more efficient to achieve this goal. However, as RCTs have not shown a mortality benefit but increase AEs, ECCOR's effects on clinical outcome remain unclear. Future studies should target patient groups that may benefit from ECCOR. PROSPERO Registration No: CRD 42020154110 (on January 24, 2021).

Citing Articles

Is there still a place for ECCOR?.

Staudinger T Med Klin Intensivmed Notfmed. 2024; 119(Suppl 2):59-64.

PMID: 39384620 PMC: 11579178. DOI: 10.1007/s00063-024-01197-x.

Expert perspectives on ECCOR for acute hypoxemic respiratory failure: consensus of a 2022 European roundtable meeting.

Combes A, Auzinger G, Camporota L, Capellier G, Consales G, Couto A Ann Intensive Care. 2024; 14(1):132.

PMID: 39174831 PMC: 11341504. DOI: 10.1186/s13613-024-01353-8.

References

Arlt M, Philipp A, Zimmermann M, Voelkel S, Amann M, Bein T . Emergency use of extracorporeal membrane oxygenation in cardiopulmonary failure. Artif Organs. 2009; 33(9):696-703. DOI: 10.1111/j.1525-1594.2009.00860.x. View

Nentwich J, Wichmann D, Kluge S, Lindau S, Mutlak H, John S . Low-flow CO removal in combination with renal replacement therapy effectively reduces ventilation requirements in hypercapnic patients: a pilot study. Ann Intensive Care. 2019; 9(1):3. PMC: 6323065. DOI: 10.1186/s13613-019-0480-4. View

Hermann A, Riss K, Schellongowski P, Bojic A, Wohlfarth P, Robak O . A novel pump-driven veno-venous gas exchange system during extracorporeal CO2-removal. Intensive Care Med. 2015; 41(10):1773-80. DOI: 10.1007/s00134-015-3957-0. View

Moss C, Galtrey E, Camporota L, Meadows C, Gillon S, Ioannou N . A Retrospective Observational Case Series of Low-Flow Venovenous Extracorporeal Carbon Dioxide Removal Use in Patients with Respiratory Failure. ASAIO J. 2016; 62(4):458-62. DOI: 10.1097/MAT.0000000000000386. View

Inal V, Efe S . Extracorporeal carbon dioxide removal (ECCO2R) in COPD and ARDS patients with severe hypercapnic respiratory failure. A retrospective case-control study. Turk J Med Sci. 2021; 51(4):2127-2135. PMC: 8569780. DOI: 10.3906/sag-2012-151. View

Seiler F, Trudzinski F, Hennemann K, Niermeyer T, Schmoll C, Kamp A . The Homburg Lung: Efficacy and Safety of a Minimal-Invasive Pump-Driven Device for Veno-Venous Extracorporeal Carbon Dioxide Removal. ASAIO J. 2017; 63(5):659-665. DOI: 10.1097/MAT.0000000000000522. View

Fischer S, Simon A, Welte T, Hoeper M, Meyer A, Tessmann R . Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. J Thorac Cardiovasc Surg. 2006; 131(3):719-23. DOI: 10.1016/j.jtcvs.2005.10.050. View

Morales-Quinteros L, Del Sorbo L, Artigas A . Extracorporeal carbon dioxide removal for acute hypercapnic respiratory failure. Ann Intensive Care. 2019; 9(1):79. PMC: 6606679. DOI: 10.1186/s13613-019-0551-6. View

Liebold A, Philipp A, Kaiser M, Merk J, Schmid F, Birnbaum D . Pumpless extracorporeal lung assist using an arterio-venous shunt. Applications and limitations. Minerva Anestesiol. 2002; 68(5):387-91. View

10.

Barrett N, Hart N, Daly K, Marotti M, Kostakou E, Carlin C . A randomised controlled trial of non-invasive ventilation compared with extracorporeal carbon dioxide removal for acute hypercapnic exacerbations of chronic obstructive pulmonary disease. Ann Intensive Care. 2022; 12(1):36. PMC: 9021560. DOI: 10.1186/s13613-022-01006-8. View

11.

Akkanti B, Jagpal S, Darwish R, Romero R, Scott L, Dinh K . Physiologic Improvement in Respiratory Acidosis Using Extracorporeal Co Removal With Hemolung Respiratory Assist System in the Management of Severe Respiratory Failure From Coronavirus Disease 2019. Crit Care Explor. 2021; 3(3):e0372. PMC: 7994071. DOI: 10.1097/CCE.0000000000000372. View

12.

Benazzo A, Schwarz S, Frommlet F, Schweiger T, Jaksch P, Schellongowski P . Twenty-year experience with extracorporeal life support as bridge to lung transplantation. J Thorac Cardiovasc Surg. 2019; 157(6):2515-2525.e10. DOI: 10.1016/j.jtcvs.2019.02.048. View

13.

Combes A, Fanelli V, Pham T, Ranieri V . Feasibility and safety of extracorporeal CO removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study. Intensive Care Med. 2019; 45(5):592-600. DOI: 10.1007/s00134-019-05567-4. View

14.

Petran J, Muelly T, Dembinski R, Steuer N, Arens J, Marx G . Validation of RESP and PRESERVE score for ARDS patients with pumpless extracorporeal lung assist (pECLA). BMC Anesthesiol. 2020; 20(1):102. PMC: 7195797. DOI: 10.1186/s12871-020-01010-0. View

15.

Camporota L, Barrett N . Current Applications for the Use of Extracorporeal Carbon Dioxide Removal in Critically Ill Patients. Biomed Res Int. 2016; 2016:9781695. PMC: 4757715. DOI: 10.1155/2016/9781695. View

16.

Karagiannidis C, Hesselmann F, Fan E . Physiological and Technical Considerations of Extracorporeal CO Removal. Crit Care. 2019; 23(1):75. PMC: 6408850. DOI: 10.1186/s13054-019-2367-z. View

17.

Braune S, Sieweke A, Brettner F, Staudinger T, Joannidis M, Verbrugge S . The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study. Intensive Care Med. 2016; 42(9):1437-44. DOI: 10.1007/s00134-016-4452-y. View

18.

Gattinoni L, Pesenti A, Mascheroni D, Marcolin R, Fumagalli R, Rossi F . Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA. 1986; 256(7):881-6. View

19.

Ricci D, Boffini M, Del Sorbo L, El Qarra S, Comoglio C, Ribezzo M . The use of CO2 removal devices in patients awaiting lung transplantation: an initial experience. Transplant Proc. 2010; 42(4):1255-8. DOI: 10.1016/j.transproceed.2010.03.117. View

20.

McNamee J, Gillies M, Barrett N, Perkins G, Tunnicliffe W, Young D . Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial. JAMA. 2021; 326(11):1013-1023. PMC: 8408762. DOI: 10.1001/jama.2021.13374. View